Pilot Intervention Study of the Impact of Sustainable Daily Physical Activity on Health and Quality of Life in a Cohort of Men With Prostate Cancer in Sweden: Steps for PRosTAte Cancer Health and Survival (SPaRTACuS)
40 Years
80 Years
Male
Prostatic Neoplasm
Trial Information
Pilot Intervention Study of the Impact of Sustainable Daily Physical Activity on Health and Quality of Life in a Cohort of Men With Prostate Cancer in Sweden: Steps for PRosTAte Cancer Health and Survival (SPaRTACuS)
Living with prostate cancer is a unique challenge faced by millions of men across the globe.
Existing research has indicated many potential methods of attenuating prostate cancer
progression and preserving patients' quality of life, but is lacking in definitive
conclusions regarding the effectiveness of these methods in practice. This study seeks to
further investigate the impact of post-diagnosis physical activity on biological indicators
of health and self-reported quality of life in a cohort of men with prostate cancer in
Sweden. Participants are randomized to either a walking intervention group, which encourages
walking 10,000 steps per day for one year, or to a standard-or-care control group, and
followed for 11 weeks.
Inclusion Criteria:
- Age 80 years or younger
- Histologic confirmation of prostate cancer
- Clinically or pathologically staged as locally advanced or early metastatic prostate
cancer
- Diagnosis within 1 year of study enrollment
- Willing and able to walk 10,000 steps per day
Exclusion Criteria:
- Age greater than 80 years old at enrollment
- Inability to understand the language spoken in host country
- Physically unable to walk 100 meters unassisted
- Diagnosed with dementia or severe psychiatric disease
- Any prior cancer diagnosis
- Has experienced a myocardial infarction or stroke within six months of cancer
diagnosis
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Principal Investigator
Ove Andren, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Orebro University
Authority:
Sweden: Institutional Review Board
Study ID:
Spartacus01
NCT ID:
NCT01696539
Start Date:
March 2010
Completion Date:
May 2010
Related Keywords:
- Prostatic Neoplasm
- Prostate Cancer
- Neoplasms
- Prostatic Neoplasms
Name | Location |
|---|
